Effect of systemic adjuvant treatment on first sites of breast cancer relapse
- 12 February 1994
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 343 (8894), 377-381
- https://doi.org/10.1016/s0140-6736(94)91221-1
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Quality-of-Life-Adjusted Evaluation of Adjuvant Therapies for Operable Breast CancerAnnals of Internal Medicine, 1991
- Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1989
- Prolonged Disease-Free Survival after One Course of Perioperative Adjuvant Chemotherapy for Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Combination Adjuvant Chemotherapy for Node-Positive Breast CancerNew England Journal of Medicine, 1988
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.Journal of Clinical Oncology, 1988
- METHOTREXATE/NITROUS-OXIDE TOXIC INTERACTION IN PERIOPERATIVE CHEMOTHERAPY FOR EARLY BREAST CANCERThe Lancet, 1987
- TOXIC EFFECTS OF EARLY ADJUVANT CHEMOTHERAPY FOR BREAST CANCERThe Lancet, 1983
- Cancer of the BreastNew England Journal of Medicine, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958